Janux Therapeutics (NASDAQ: JANX) stock is crushing it. The stock was up 42.4% for the week as of market close on Thursday, according to data from S&P Global Market Intelligence.

The big gain came after Bloomberg reported on Wednesday that Janux was exploring a potential sale. Big drugmakers have expressed interest in acquiring Janux, according to anonymous sources interviewed by Bloomberg.

Janux hasn't publicly commented on the reported acquisition talks. Some investors might think management's silence hints there's truth to the rumors.

Continue reading

Source Fool.com